GDX vs IBB
VanEck Gold Miners ETF vs iShares Biotechnology ETF
GDX$86.19
VanEck Gold Miners ETF
Major gold mining companies.
Expense: 0.51%Yield: 0.82%
IBB$217.75
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.16%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 0.51% for GDX.
- • GDX pays a higher dividend yield (0.82%).
Side-by-side metrics
| Metric | GDX | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.51% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.82% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $23.82B | $11.50B |
YTD return | 6.63% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 0.60 |
P/E ratio | 13.66 | 25.48 |
Last price | $86.19 | $217.75 |
Inception | — | — |
Issuer | VanEck | iShares |
GDX top holdings
Top holdings · GDX
| NEM | Newmont Corp | 11.62% |
| AEM.TO | Agnico Eagle Mines Ltd | 11.26% |
| ABX.TO | Barrick Mining Corp | 8.18% |
| WPM.TO | Wheaton Precious Metals Corp | 5.48% |
| FNV.TO | Franco-Nevada Corp | 5.45% |
| AU | Anglogold Ashanti PLC | 4.73% |
| GFI | Gold Fields Ltd ADR | 3.92% |
| K.TO | Kinross Gold Corp | 3.65% |
| NST.AX | Northern Star Resources Ltd | 3.28% |
| PAAS.TO | Pan American Silver Corp | 2.55% |
Sector breakdown · GDX
Basic Materials100.0%
IBB top holdings
Top holdings · IBB
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
Sector breakdown · IBB
Healthcare100.0%
About GDX
GDX (VanEck Gold Miners ETF) is Major gold mining companies. Managed by VanEck, the fund carries $23.8B in assets under management, an expense ratio of 0.51%, a dividend yield of 0.82%. Its largest holding is Newmont Corp (NEM), which represents 11.6% of the portfolio. Basic Materials is the fund's largest sector exposure at 100.0%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.